Status:
COMPLETED
Influence of DHA-rich Supplement on DHA-status and Health Evolution of Patients With Cystic Fibrosis
Lead Sponsor:
University Hospital, Ghent
Collaborating Sponsors:
Belgian Society against Cystic Fibrosis
Conditions:
Cystic Fibrosis
Eligibility:
All Genders
6+ years
Phase:
PHASE2
Brief Summary
Investigation of the influence of giving DHA-rich supplement versus placebo on DHA-status and health evolution of patients with cystic fibrosis
Detailed Description
Investigation of the influence of giving DHA-rich supplement versus placebo on DHA-status and health evolution of patients with cystic fibrosis
Eligibility Criteria
Inclusion
- Delta F 508 homozygote
- Stable clinical situation
Exclusion
- \-
Key Trial Info
Start Date :
September 1 2007
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
September 1 2008
Estimated Enrollment :
17 Patients enrolled
Trial Details
Trial ID
NCT00221546
Start Date
September 1 2007
End Date
September 1 2008
Last Update
September 28 2011
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University Hospital Ghent
Ghent, Belgium, 9000